Los Angeles, Calif., October
30, 2007
Elekta, a pioneer in the field of stereotactic radiosurgery,
currently is showcasing the broadest portfolio of stereotactic
technology in the industry at the 49th Annual Meeting of The
American Society for Therapeutic Radiology and Oncology (ASTRO).
Held October 28-November 1 at the Los Angeles Convention Center,
ASTRO is the perfect forum for Elekta to showcase its latest
products covering the full spectrum of stereotactic systems and
solutions for planning, immobilization, treatment and
post-processing.
“No other vendor has the breadth of solutions that Elekta offers
its users,” says Tomas Puusepp, Elekta President and CEO. “We
provide innovations through the continuum of care that help
fight serious disease and improve quality of life for patients.”
Of the many programs that have acquired or plan to acquire a new
linear accelerator within the next few years, the majority are
adding radiosurgery capabilities. With its broad portfolio of
solutions, Elekta is uniquely positioned to offer cancer
programs the solutions they deem best for delivering
radiosurgery.
Leksell Gamma Knife® Perfexion™ offers state-of-the-art
radiosurgery with expanded treatment reach
The newest generation Leksell Gamma Knife® is Leksell Gamma
Knife® Perfexion™. Leksell Gamma Knife is the only radiation
therapy device cleared by the FDA for the treatment of brain
metastases. Brain metastases, tumors originating from cancer in
other parts of the body, have been increasing in incidence
worldwide, and traditional treatments for these tumors often
involve a long period of recovery, as well as side effects like
nausea, vomiting and hair loss. Stereotactic radiosurgery with
Leksell Gamma Knife Perfexion offers dramatic improvements in
quality of life for brain metastases patients, with
single-session treatments, faster recovery time and virtually no
side effects.
For clinicians, Leksell Gamma Knife Perfexion offers absolute
protocol reproducibility, allowing access to extensive Leksell
Gamma Knife clinical experience from around the world. In
addition, it gives virtually unlimited dose sculpting ability
for sub-millimeter accuracy in targeting tumors of any shape,
and expands treatment reach to a wider range of anatomical
structure, enabling clinicians to treat more patients.
The new Leksell GammaPlan® PFX™ treatment planning software, now
running on a PC-based platform, is as sophisticated as the
system it controls. Providing enhanced, user-friendly management
of Leksell Gamma Knife Perfexion technology, Leksell GammaPlan
PFX gives superior dosimetry performance and excellent radiation
protection for both the radiosurgery team and their patients.
Elekta Axesse™ provides excellence in SRS and SRT
In addition to innovative cranial radiosurgery solutions, Elekta
is displaying Elekta Axesse™, a comprehensive and integrated
full-body solution for performing both stereotactic radiosurgery
(SRS) and stereotactic radiation therapy (SRT). Elekta Axesse
combines true three-dimensional image guidance at the time of
treatment with highly conformal beam shaping and robotically
controlled 6D sub-millimeter patient positioning to deliver
fast, efficient and accurate treatment. All treatment processes
from planning to delivery are controlled from a single
workstation to streamline workflow.
Elekta Synergy® is the Multi-Functional IGRT solution
Elekta Synergy® with X-ray Volume Imaging (XVI) enables
clinicians to visualize internal structures, including soft
tissues, in three dimensions at the time of treatment and in the
same frame of reference. This innovative feature minimizes
geometric uncertainties from organ motion and deformation as
well as slight differences in patient set-up. Elekta Synergy
inspires clinical confidence to undertake advanced radiation
therapy techniques such as Intensity Modulated Arc Therapy
(IMRT) and Image Guided Radiation Therapy (IGRT).
Upgrades for even more efficient stereotactic workflow with
Elekta Synergy will be displayed at ASTRO. Medical Intelligence,
an Elekta company, will display the non-invasive HeadFIX® and
BodyFIX® patient-specific immobilization devices, which are
vacuum-activated for highly accurate and reproducible
positioning and immobilization. Elekta is showing three new
micro multileaf collimators (MLCs), the most versatile
technology available for SRS and SRT. All three micro MLCs – the
3mm, the 5mm and the 7mm leaf width – have improved dose shaping
abilities for minimal risk to critical organs.
Illustrious history, solid future in stereotaxy
“Elekta’s stereotactic products demonstrate its commitment to
technological innovation and advances in stereotaxy,” says
Puusepp. Elekta was founded by the late professor Lars Leksell,
a pioneer in minimally invasive surgery and inventor of the
Leksell Stereotactic System® in 1948 and Leksell Gamma Knife in
1968. Since, Elekta has continued to set new standards in
accuracy and therapeutic efficacy in both stereotactic radiation
therapy and stereotactic radiosurgery.
“As Elekta develops high quality cost-effective solutions,
cancer centers around the world are taking a major interest in
adding whole-body radiosurgery to their radiation therapy
capabilities,” says Puusepp.
About Elekta
Elekta is an international medical technology group, providing
oncologists, radiation therapists, neurosurgeons and many other
medical specialists with state of the art tools to fight serious
disease.
Elekta provides advanced clinical solutions, comprehensive
management and information systems as well as services for
improved cancer care and management of brain disorders.
Elekta’s systems and solutions are used in over 4,500 hospitals
around the world. Clinical and information management solutions
include, among others, Leksell Gamma Knife® for non-invasive
treatment of brain disorders, Elekta Axesse™ and Elekta Synergy®
for stereotactic and image guided radiation therapy and
radiosurgery as well as the MOSAIQ™ suite of software for
image-enabled EMR and efficient management of clinical and
patient data.
With more than 2,000 employees globally, the corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Nordic Exchange under the ticker EKTAb. More
information about Elekta can be found at www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries: Peter Gaccione
Vice President,
Global Marketing
Tel: +1 770-670-2380
peter.gaccione@elekta.com
Investor inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Link Disclaimer
|
